Zanosar Side Effects
Generic name: streptozocin
Note: This document contains side effect information about streptozocin. Some of the dosage forms listed on this page may not apply to the brand name Zanosar.
Some side effects of Zanosar may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to streptozocin: intravenous powder for injection
If you experience any of the following serious side effects from streptozocin (the active ingredient contained in Zanosar) contact your doctor immediately or seek emergency medical attention:
-
an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
-
kidney damage (little or no urine production, blood in the urine);
-
liver problems (changes in blood test results, abdominal pain, yellowing of the skin or eyes, decreased appetite, nausea);
-
decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection); or
-
severe nausea, vomiting, loss of appetite, or diarrhea.
In some cases, secondary cancers have been reported to occur during and following treatment with streptozocin. Talk to your doctor about the risks and benefits of this medication.
Other, less serious side effects may be more likely to occur. Continue taking streptozocin and talk to your doctor if you experience:
-
mild nausea, vomiting, loss of appetite, or diarrhea;
-
drowsiness;
-
confusion;
-
depression; or
-
swelling, redness, burning, or tenderness at the injection site.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to streptozocin: intravenous powder for injection
Renal
Renal toxicity is dose-related and cumulative. Adequate hydration may help reduce the risk of nephrotoxicity to renal tubular epithelium by decreasing renal and urinary concentration of the drug and its metabolites.
Renal side effects have included severe and sometimes fatal renal toxicity, azotemia, anuria, hypophosphatemia, glycosuria, and renal tubular acidosis. A case of chronic renal failure has also been reported.
Hematologic
Hematologic side effects have included fatal hematologic toxicity with substantial reductions in leukocyte and platelet counts. In most cases, hematologic toxicity only involves mild decreases in hematocrit values.
Gastrointestinal
Severe nausea and vomiting have occasionally required the discontinuation of therapy.
Gastrointestinal side effects have included severe nausea and vomiting. Diarrhea has also been reported.
Metabolic
Abnormalities of glucose tolerance have generally been reversible.
Metabolic side effects have included mild to moderate abnormalities of glucose tolerance. Insulin shock with hypoglycemia has also been reported.
Local
In most cases, local effects have been reported to resolve either the same day or within a few days.
Local side effects following extravasation have included erythema, burning, and tenderness.
Hepatic
Hepatic side effects have included hypoalbuminemia and elevated SGOT and LDH levels.
Genitourinary
Genitourinary side effects have included two cases of nephrogenic diabetes insipidus.
One case of nephrogenic diabetes insipidus was reported to have had a spontaneous recovery while the second case responded to indomethacin.
More Zanosar resources
- Zanosar Prescribing Information (FDA)
- Zanosar Concise Consumer Information (Cerner Multum)
- Zanosar Monograph (AHFS DI)
- Zanosar MedFacts Consumer Leaflet (Wolters Kluwer)
- Zanosar Advanced Consumer (Micromedex) - Includes Dosage Information
- Streptozocin Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


